aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded over a decade ago, Augmedix, Inc. is dedicated to revolutionizing healthcare documentation through advanced technology. The company’s core mission is to streamline medical documentation processes, allowing healthcare providers to focus more on patient care. Augmedix offers EHR-integrated AI documentation services that convert natural conversations into structured medical notes, catering to various specialties including ambulatory and acute care. Their market focus spans health systems and independent practices across the United States.
Augmedix has garnered trust from some of the nation's top healthcare organizations, producing approximately 70,000 notes per week. Notable affiliated individuals include experienced healthcare professionals and tech innovators who drive the company’s mission forward. Key investors have supported Augmedix in achieving significant milestones, such as enhancing operational efficiency and clinical decision support for their clients. The overall impact of Augmedix is evident in its ability to improve documentation accuracy and reduce administrative burdens for healthcare providers.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Data Services, Medical Documentation
Technology
AI, Machine Learning
Tags
Healthtech, Ai Operations
Model Types
Professional Services, Software
Revenue Type(s)
Recurring, Consulting
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Augmedix founded?
Augmedix was founded in 2012.
Where is Augmedix’s headquarters located?
Augmedix’s headquarters is located in San Francisco, CA, US.
When was Augmedix’s last funding round?
Augmedix’s most recent funding round was for $25M (USD) in November 2023.
How many employees does Augmedix have?
Augmedix has 1040 employees as of Feb 6, 2024.
How much has Augmedix raised to-date?
As of July 05, 2023, Augmedix has raised a total of $161.7M (USD) since Nov 15, 2023.
Add Comparison
Total Raised to Date
$161.7M
USD
Last Update Nov 15, 2023
Last Deal Details
$25M
USD
Nov 15, 2023
Post Ipo Equity
Total Employees Over Time
1040
As of Feb 2024
Augmedix Address
111 Sutter St
suite 1300
San Francisco,
California
94104
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts